CRVSCorvus Pharmaceuticals, Inc.
What is the market doing?
The market is leaning against it: in a downtrend (−24% vs 200-day) and a crowded short (+19% of shares).
In a downtrend, below its 50- and 200-day averages. Price is −24% vs its 200-day average.
A crowded short, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CRVS is trading
Corvus Pharmaceuticals, Inc. is +79% over the past year while the S&P 500 is +18%: 61 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −24%
vs 200-day average · a clear downtrend
- RSI (14)
- 32
RSI (14) · neutral
- Below its 52-week high
- 59%
Below its 52-week high
Details›
- Last close2026-10-09
- $10.52
- 1 monthS&P 500 +2.7%
- −19%
- 1 yearS&P 500 +18%
- +79%
- 5 yearsS&P 500 +88%
- +370%
- vs 50-day average$13.19
- −20%
- 52-week high
- $25.52
- 52-week low
- $6.04
- Annualised volatility
- 141%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $334K
| Year | Return |
|---|---|
| 2026 (year to date) | +37% |
| 2025 | +44% |
| 2024 | +204% |
| 2023 | +107% |
| 2022 | −65% |
| 2021 | −32% |
| 2020 | −35% |
| 2019 | +48% |
| 2018 | −65% |
| 2017 | −28% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +15% |
| Feb | 10 | 3 of 10 | −6.1% |
| Mar | 10 | 3 of 10 | −2.6% |
| Apr | 10 | 5 of 10 | −5.5% |
| May | 10 | 6 of 10 | +26% |
| Jun | 10 | 3 of 10 | −5.9% |
| Jul | 11 | 6 of 11 | +5.1% |
| Aug | 11 | 8 of 11 | +14% |
| Sep | 11 | 5 of 11 | +8.0% |
| Oct | 11 | 4 of 11 | +0.82% |
| Nov | 10 | 6 of 10 | +0.43% |
| Dec | 10 | 2 of 10 | −6.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.